YIH
SPPI

Y-Intercept (HK)’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Y-Intercept (HK)’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,513
Closed -$21K – 1363
2022
Q2 		$21K Buy
+26,513
New +$23.4K ﹤0.01% 790

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Y-Intercept (HK)'s SPPI Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 26,513 shares — an estimated $21K sold.

Y-Intercept (HK) first reported a position in SPPI in Q2 2022 and held it in 1 quarter. The position peaked at $21K in Q2 2022. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • Y-Intercept (HK) reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 26,513 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $21K.
  • Y-Intercept (HK) first reported a position in Spectrum Pharmaceuticals Inc in Q2 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s Spectrum Pharmaceuticals Inc position peaked at $21K in Q2 2022.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.